Trastuzumab plus Chemotherapie bei metastasierendem MagenkarzinomTrastuzumab plus chemotherapy for metastatic gastric cancer

被引：0
|
作者：
K. Schulte
机构：
[1] Kliniken der Stadt Köln gGmbH,Medizinische Klinik
[2] Krankenhaus Holweide,undefined
来源：
Der Gastroenterologe | 2010年 / 5卷 / 6期
关键词：
D O I：
10.1007/s11377-010-0484-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：540 / 541
页数：1
相关论文
共 50 条
  • [41] A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
    Nakamura, Naohiko
    Kinami, Shinichi
    Fujii, Yoritaka
    Miura, Seiko
    Fujita, Jun
    Kaida, Daisuke
    Tomita, Yasuto
    Miyata, Takashi
    Fujita, Hideto
    Ueda, Nobuhiko
    Kosakae, Takeo
    CLINICAL CASE REPORTS, 2019, 7 (04): : 714 - 718
  • [42] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    MEDICINE, 2016, 95 (51) : e4531
  • [43] Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis
    Cai, Hongfu
    Fang, Ling
    Lin, Jingwen
    Zheng, Zhiwei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [44] KEYNOTE-826: PEMBROLIZUMAB PLUS CHEMOTHERAPY VERSUS PLACEBO PLUS CHEMOTHERAPY FOR PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER
    Colombo, N.
    Dubot, C.
    Lorusso, D.
    Caceres, V.
    Hasegawa, K.
    Shapira-Frommer, R.
    Tewari, K.
    Salman, P.
    Usta, E. Hoyos
    Yanez, E.
    Gumus, M.
    de Mendoza, M. Olivera Hurtado
    Samouelian, V.
    Castonguay, V.
    Arkhipov, A.
    Toker, S.
    Li, K.
    Keefe, S.
    Monk, B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A364 - A364
  • [45] Nivolumab plus chemotherapy for advanced gastric cancer and oesophageal adenocarcinoma
    Hindson J.
    Nature Reviews Gastroenterology & Hepatology, 2021, 18 (8) : 523 - 523
  • [46] Lapatinib Plus Trastuzumab for a Patient with Heavily Pre-treated Gastric Cancer that Progressed after Trastuzumab
    Shitara, Kohei
    Mizota, Ayako
    Yatabe, Yasushi
    Kondo, Chihiro
    Nomura, Motoo
    Yokota, Tomoya
    Takahari, Daisuke
    Ura, Takashi
    Muro, Kei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (05) : 663 - 665
  • [47] Trastuzumab plus chemotherapy versus chemotherapy alone in HER2-positive gastric cancer treatment in Iran: a cost-effectiveness analysis
    Kaveh, Sara
    Ghadimi, Nashmil
    Alvar, Amirhossein Zarei
    Roudini, Kamran
    Daroudi, Rajabali
    HEALTH ECONOMICS REVIEW, 2024, 14 (01):
  • [48] First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: Cost-minimization analysis
    Nerich, Virginie
    Chelly, Jennifer
    Montcuquet, Philippe
    Chaigneau, Loic
    Villanueva, Cristian
    Fiteni, Frederic
    Meneveau, Nathalie
    Perrin, Sophie
    Voidey, Aline
    Monnot, Tess
    Pivot, Xavier
    Limat, Samuel
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (05) : 362 - 368
  • [49] Chemotherapy with trastuzumab plus vinorelbine in patients with erb-B2 overexpressed tumor is active in metastatic breast cancer.
    Filipovich, E
    Mayordomo, JI
    Isla, D
    Andres, R
    Escudero, P
    Alvarez, I
    Saenz, A
    Polo, E
    Lara, R
    Tres, A
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S112 - S112
  • [50] Pertuzumab (P) plus trastuzumab (H) plus chemotherapy (CT) for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (mGC/GEJC): Final analysis of a Phase III study (JACOB)
    Tabernero, J.
    Hoff, P. M.
    Shen, L.
    Ohtsu, A.
    Shah, M. A.
    Cheng, K.
    Song, C.
    Wu, H.
    Eng-Wong, J.
    Kang, Y-K.
    ANNALS OF ONCOLOGY, 2017, 28
12345